SEC Form 4 · accession 0001645470-19-000014
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Feb 19, 2019
Accepted (ET)
Feb 25, 2019 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2019 | P | 5,000 | $0.024 | A | 21,558,123 | D | |
| Common Stock | Feb 19, 2019 | P | 5,000 | $0.0229 | A | 21,563,123 | D | |
| Common Stock | Feb 19, 2019 | P | 10,000 | $0.0229 | A | 21,573,123 | D | |
| Common Stock | Feb 19, 2019 | P | 5,000 | $0.0228 | A | 21,578,123 | D | |
| Common Stock | Feb 19, 2019 | P | 5,000 | $0.0239 | A | 21,583,123 | D | |
| Common Stock | Feb 20, 2019 | P | 5,000 | $0.024 | A | 21,588,123 | D | |
| Common Stock | Feb 20, 2019 | P | 5,000 | $0.023 | A | 21,593,123 | D | |
| Common Stock | Feb 21, 2019 | P | 5,000 | $0.0226 | A | 21,598,123 | D | |
| Common Stock | Feb 21, 2019 | P | 5,000 | $0.0228 | A | 21,603,123 | D |
Table II — derivative securities
No Table II lines on this filing.